Arcadia Biosciences (RKDA) Short Interest Ratio & Short Volume $4.75 +0.12 (+2.59%) Closing price 07/3/2025 03:25 PM EasternExtended Trading$4.65 -0.10 (-2.11%) As of 07/3/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Arcadia Biosciences Short Interest DataArcadia Biosciences (RKDA) has a short interest of 22,300 shares, representing 1.64% of the float (the number of shares available for trading by the public). This marks a 67.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 310,294 shares to cover all short positions.Current Short Interest22,300 sharesPrevious Short Interest13,300 sharesChange Vs. Previous Month+67.67%Dollar Volume Sold Short$110.39 thousandShort Interest Ratio1.8 Days to CoverLast Record DateJune 15, 2025Outstanding Shares1,370,000 sharesFloat Size1,360,000 sharesShort Percent of Float1.64%Today's Trading Volume79,150 sharesAverage Trading Volume310,294 sharesToday's Volume Vs. Average26% Short Selling Arcadia Biosciences? Sign up to receive the latest short interest report for Arcadia Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRKDA Short Interest Over TimeRKDA Days to Cover Over TimeRKDA Percentage of Float Shorted Over Time Arcadia Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202522,300 shares $110.39 thousand +67.7%1.6%1.8 $4.95 5/31/202513,300 shares $62.51 thousand -31.1%1.0%1.1 $4.70 5/15/202519,300 shares $74.69 thousand +58.2%1.4%1.9 $3.87 4/30/202512,200 shares $42.70 thousand -7.6%0.9%1.4 $3.50 4/15/202513,200 shares $39.20 thousand -1.5%1.0%1.8 $2.97 3/31/202513,400 shares $38.00 thousand +30.1%1.0%1.6 $2.84 3/15/202510,300 shares $34.24 thousand -16.9%0.8%0.7 $3.32 2/28/202512,400 shares $48.48 thousand -17.3%0.9%0 $3.91 2/15/202515,000 shares $72.15 thousand +102.7%1.1%0 $4.81 1/31/20257,400 shares $35.82 thousand -45.6%0.6%0 $4.84 Get the Latest News and Ratings for RKDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arcadia Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202513,600 shares $69.63 thousand -68.8%1.0%0 $5.12 12/31/202443,600 shares $258.11 thousand -62.5%3.2%0 $5.92 12/15/2024116,100 shares $731.43 thousand +1,175.8%8.5%0.1 $6.30 11/30/20249,100 shares $25.39 thousand -53.6%0.7%0 $2.79 11/15/202419,600 shares $56.84 thousand -21.3%1.4%1.4 $2.90 10/31/202424,900 shares $96.11 thousand +43.1%4.1%1.9 $3.86 10/15/202417,400 shares $49.07 thousand -19.4%2.8%1.6 $2.82 9/30/202421,600 shares $58.97 thousand -17.2%3.5%2.7 $2.73 9/15/202426,100 shares $72.82 thousand -13.3%4.3%3 $2.79 8/31/202430,100 shares $93.53 thousand +1.4%4.9%3.5 $3.11 8/15/202429,700 shares $82.27 thousand -29.8%4.9%2.9 $2.77 7/31/202442,300 shares $115.48 thousand -24.5%7.1%1.8 $2.73 7/15/202456,000 shares $171.08 thousand -1.4%9.3%2.4 $3.06 6/30/202456,800 shares $178.92 thousand -9.4%9.5%2.2 $3.15 6/15/202462,700 shares $198.64 thousand -13.3%10.4%2.3 $3.17 5/31/202472,300 shares $221.24 thousand +1,264.2%12.0%2.4 $3.06 5/15/20245,300 shares $15.48 thousand -50.5%0.9%0.2 $2.92 4/30/202410,700 shares $21.94 thousand +161.0%1.8%0.5 $2.05 4/15/20244,100 shares $7.75 thousand +10.8%0.7%0.2 $1.89 3/31/20243,700 shares $8.18 thousand No Change0.6%0.2 $2.21 3/15/20243,700 shares $9.44 thousand -9.8%0.6%0.1 $2.55 2/29/20244,100 shares $11.69 thousand +51.9%0.7%0.1 $2.85 2/15/20242,700 shares $7.97 thousand +80.0%0.5%0.1 $2.95 1/31/20241,500 shares $3.59 thousand -91.0%0.3%0 $2.39 1/15/202416,600 shares $43.99 thousand +97.6%2.8%0.5 $2.65 12/31/20238,400 shares $26.29 thousand -19.2%1.4%0.2 $3.13 12/15/202310,400 shares $30.37 thousand +82.5%1.7%0.5 $2.92 11/30/20235,700 shares $16.53 thousand +18.8%1.0%0.3 $2.90 11/15/20234,800 shares $14.78 thousand -52.9%0.8%0.3 $3.08 10/31/202310,200 shares $34.97 thousand +100.0%1.7%0.6 $3.43Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 10/15/20235,100 shares $16.01 thousand -8.9%0.9%0.3 $3.14 9/30/20235,600 shares $18.76 thousand +33.3%0.9%0.2 $3.35 9/15/20234,200 shares $15.41 thousand +600.0%0.7%0.1 $3.67 8/31/2023600 shares $2.10 thousand -87.2%0.1%0 $3.50 8/15/20234,700 shares $20.54 thousand -57.7%0.8%0.1 $4.37 7/31/202311,100 shares $49.06 thousand -33.1%1.9%0.3 $4.42 7/15/202316,600 shares $74.04 thousand +44.4%2.8%0.3 $4.46 6/30/202311,500 shares $44.62 thousand +29.2%1.9%0.3 $3.88 6/15/20238,900 shares $37.02 thousand -29.9%1.5%0.3 $4.16 5/31/202312,700 shares $58.29 thousand +2.4%2.2%0.4 $4.59 5/15/202312,400 shares $61.01 thousand -69.8%2.1%0.1 $4.92 4/30/202341,000 shares $250.10 thousand -1.9%6.9%0.3 $6.10 4/15/202341,800 shares $278.81 thousand +1.0%7.1%0.3 $6.67 3/31/202341,400 shares $309.26 thousand -42.8%7.1%0.3 $7.47 3/15/202372,400 shares $528.52 thousand +2,684.6%12.3%0.5 $7.30 2/28/20232,600 shares $650.26 -97.5%0.4%0 $0.25 2/15/2023102,700 shares $27.73 thousand +13.5%N/A0.4 $0.27 1/31/202390,500 shares $23.50 thousand -23.1%N/A0.4 $0.26 1/15/2023117,700 shares $42.36 thousand +16.3%N/A0.6 $0.36 12/30/2022101,200 shares $27.43 thousand -63.2%N/A0.5 $0.27 12/15/2022274,900 shares $87.91 thousand -38.1%N/A1.5 $0.32 11/30/2022443,800 shares $148.76 thousand -28.7%N/A2.4 $0.34 11/15/2022622,500 shares $208.29 thousand +83.6%N/A3.1 $0.33 10/31/2022339,000 shares $142.72 thousand -10.9%N/A1.7 $0.42 10/15/2022380,400 shares $154.59 thousand -6.7%N/A2.3 $0.41 9/30/2022407,800 shares $215.28 thousand -3.0%N/A2.7 $0.53 9/15/2022420,200 shares $322.71 thousand -12.0%N/A2.7 $0.77 8/31/2022477,500 shares $416.62 thousand -10.1%N/A2.9 $0.87 8/15/2022531,400 shares $526.09 thousand +14.6%N/A2.9 $0.99 7/31/2022463,800 shares $388.66 thousand -1.9%2.2%1.4 $0.84 7/15/2022472,700 shares $466.79 thousand +13.3%2.3%1.3 $0.99 6/30/2022417,400 shares $417.40 thousand -29.6%2.0%0.9 $1.00 6/15/2022592,900 shares $610.69 thousand -16.8%2.8%0.7 $1.03 5/31/2022712,600 shares $976.26 thousand +9.7%3.4%0.3 $1.37 5/15/2022649,600 shares $656.10 thousand -14.6%3.1%0.3 $1.01 4/30/2022760,900 shares $734.27 thousand -25.4%3.6%0.3 $0.97 4/15/20221,020,000 shares $1.09 million -19.1%4.9%0.5 $1.07 3/31/20221,260,000 shares $1.76 million -58.4%6.0%0.5 $1.40 3/15/20223,030,000 shares $4.51 million +311.7%14.4%1.3 $1.49 2/28/2022735,900 shares $732.22 thousand -23.1%3.5%0.6 $1.00 2/15/2022956,900 shares $995.18 thousand -8.0%4.6%1 $1.04 1/31/20221,040,000 shares $908.96 thousand -9.6%5.1%1.1 $0.87 1/15/20221,150,000 shares $1.18 million +30.7%5.7%1.1 $1.03 12/31/2021880,100 shares $915.30 thousand +8.8%4.3%1 $1.04 12/15/2021809,000 shares $809 thousand -5.7%4.0%2.4 $1.00 11/30/2021857,700 shares $1.11 million -19.1%4.2%2.8 $1.29 11/15/20211,060,000 shares $2.18 million +6.9%5.2%3.4 $2.06 10/29/2021991,600 shares $1.93 million +11.1%4.9%3.3 $1.95 10/15/2021892,200 shares $1.81 million -8.2%4.4%3.6 $2.03 9/30/2021971,600 shares $2.01 million -30.1%4.8%3.3 $2.07Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 9/15/20211,390,000 shares $2.99 million -2.8%6.8%4.1 $2.15 8/31/20211,430,000 shares $3.46 million +7.5%7.1%2.9 $2.42 8/13/20211,330,000 shares $3.13 million +7.3%6.6%2.3 $2.35 7/30/20211,240,000 shares $2.91 million -4.6%6.4%2 $2.35 7/15/20211,300,000 shares $3.43 million +13.0%6.7%1.5 $2.64 6/30/20211,150,000 shares $3.42 million +13.9%5.9%1.3 $2.97 6/15/20211,010,000 shares $2.75 million -9.8%5.2%0.4 $2.72 5/28/20211,120,000 shares $3.17 million -15.8%5.7%0.5 $2.83 5/14/20211,330,000 shares $3.15 million -2.2%N/A0.6 $2.37 4/30/20211,360,000 shares $3.67 million -19.1%N/A0.4 $2.70 4/15/20211,680,000 shares $4.25 million +40.0%N/A0.6 $2.53 3/31/20211,200,000 shares $2.80 million +13.2%N/A0.4 $2.33 3/15/20211,060,000 shares $3.28 million +6.7%N/A0.6 $3.09 2/26/2021993,100 shares $3.16 million -64.9%N/A0.6 $3.18 2/12/20212,830,000 shares $12.99 million +44.4%N/A1.9 $4.59 1/29/20211,960,000 shares $5.64 million +851.9%N/A3.3 $2.88 1/15/2021205,900 shares $580.64 thousand +35.6%N/A0.5 $2.82 12/31/2020151,900 shares $378.23 thousand +56.9%N/A0.5 $2.49 12/15/202096,800 shares $294.27 thousand +39.7%N/A0.4 $3.04 11/30/202069,300 shares $230.61 thousand -65.4%N/A0.3 $3.33 11/15/2020200,300 shares $562.84 thousand -44.5%N/A1 $2.81 10/30/2020361,000 shares $1.12 million -32.8%N/A1.8 $3.09 10/15/2020536,900 shares $1.82 million -1.6%N/A2.6 $3.39 9/30/2020545,600 shares $1.53 million +20.0%N/A2.4 $2.80 9/15/2020454,600 shares $1.39 million -6.1%N/A2.1 $3.06 8/31/2020483,900 shares $1.51 million +10.0%N/A2.3 $3.12 8/14/2020439,800 shares $1.45 million +3.6%N/A2 $3.30 7/31/2020424,400 shares $1.51 million +22.9%N/A1.8 $3.56 7/15/2020345,400 shares $1.27 million +17.2%N/A1.5 $3.67 RKDA Short Interest - Frequently Asked Questions What is Arcadia Biosciences' current short interest? Short interest is the volume of Arcadia Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 22,300 shares of RKDA short. 1.64% of Arcadia Biosciences' shares are currently sold short. Learn More on Arcadia Biosciences' current short interest. What is a good short interest ratio for Arcadia Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RKDA shares currently have a short interest ratio of 2.0. Learn More on Arcadia Biosciences's short interest ratio. What is a good short interest percentage for Arcadia Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.64% of Arcadia Biosciences' floating shares are currently sold short. Is Arcadia Biosciences' short interest increasing or decreasing? Arcadia Biosciences saw a increase in short interest in June. As of June 15th, there was short interest totaling 22,300 shares, an increase of 67.7% from the previous total of 13,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Arcadia Biosciences' float size? Arcadia Biosciences currently has issued a total of 1,370,000 shares. Some of Arcadia Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Arcadia Biosciences currently has a public float of 1,360,000 shares. How does Arcadia Biosciences' short interest compare to its competitors? 1.64% of Arcadia Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Arcadia Biosciences: Local Bounti Corporation (0.48%), Nocera, Inc. (0.52%), S&W Seed Company (0.35%), Inspire Veterinary Partners, Inc. (3.36%), Origin Agritech Limited (0.16%), SHINECO (10.78%), Edible Garden AG Incorporated (6.83%), African Agriculture Holdings Inc. (2.19%), Corteva, Inc. (1.03%), BrightView Holdings, Inc. (6.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Arcadia Biosciences stock? Short selling RKDA is an investing strategy that aims to generate trading profit from Arcadia Biosciences as its price is falling. RKDA shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arcadia Biosciences? A short squeeze for Arcadia Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RKDA, which in turn drives the price of the stock up even further. How often is Arcadia Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RKDA, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Local Bounti Short Interest Data Nocera Short Interest Data S&W Seed Short Interest Data Inspire Veterinary Partners Short Interest Data Origin Agritech Short Interest Data SHINECO Short Interest Data Edible Garden Short Interest Data African Agriculture Short Interest Data African Agriculture Short Interest Data Edible Garden Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RKDA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RKDA Stock Alerts